Clinical Trial Detail

NCT ID NCT04194554
Title A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (ASCLEPIuS)
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Leuprolide + Niraparib + Prednisone

Age Groups: adult senior

No variant requirements are available.